Mirjana Perković Benedik

Mirjana Perković Benedik

Auto-generated profile, based on publicly available information

Mirjana Perković Benedik

University Medical Centre Ljubljana

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2020 in Epilepsy & Behavior
Verified
Journal Article
Closed access
EVEva Vrščaj
Eva Vrščaj
MBMirjana Perković Benedik
Mirjana Perković Benedik
JMJasna Oražem Mrak
Jasna Oražem Mrak
NBNeli Bizjak
Neli Bizjak
Damjan OsredkarDamjan Osredkar
Damjan Osredkar

1 January 2026
Verified
Book
Closed access
AOAleksandra Aleksandrova Oberstar
Aleksandra Aleksandrova Oberstar
Tadej AvĉinTadej Avĉin
Tadej Avĉin
DBDenis Baš
Denis Baš
NBNina Battelino
Nina Battelino
MBMaša Bizjak
Maša Bizjak
VŽVesna Žličar
Vesna Žličar

28 April 2025 in medRxiv
Verified
Preprint
Open access
PDF file
NDNeubauer David
Neubauer David
ŽDŽigon Dušan
Žigon Dušan
PMPerković Benedik Mirjana
Perković Benedik Mirjana
BNBizjak Neli
Bizjak Neli
JKJasna Kovač
Jasna Kovač
Damjan OsredkarDamjan Osredkar
Damjan Osredkar
Introduction: Some parents initiate treatment with non-prescription, home-made (unlabeled and unregulated) cannabis products for their children with refractory epilepsy without consulting their physicians. This study aimed to analyze the composition of these products in a pediatric cohort. Methods: Home-made cannabis samples were analyzed for cannabinoid content, cannabidiol (CBD):Δ9-tetrahydrocannabinol (THC) ratio, and potential contaminants. Results: Sixty home-made cannabis samples from 31 patients were analyzed. The most frequently detected cannabinoids were CBD, THC, and their acidic forms. The CBD:THC ratio varied significantly, with the most common ratio ranging from 1:1 to 10:1 (25.0%). Approximately 11.7% of the samples contained mainly CBD, 38.3% contained more THC than CBD, and 18.3% contained primarily THC with undetectable CBD levels. Conclusions: Health professionals should strongly discourage the use of unregulated home-made cannabis products, as undisclosed and highly variable cannabinoid content with often elevated THC levels and potential contaminants present serious health risks for children with refractory epilepsy.